AzTrials
AzTrials

HealthyNCT03201341

Multisensory Body and Space Representations (BASES-EXTINCTION)

A study testing Electrooculogram (EOG), Surface Electromyography (EMG) and Electrodermal response in people with Healthy and Blindness, run by Hospices Civils de Lyon at 1 site in France.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

To accurately control body movements to interact with objects, our brain needs representations of the body and the nearby space. The broader aim of this research project is to study the behavioural and physiological mechanisms involved in the constitution of these representations, to identify their neural bases, in… Read more about this study

Who is it for?
Ages 5 to 71 yearsHealthy volunteers can take part
Conditions the study is for
Healthy, Blindness
What is being tested?
Electrooculogram (EOG), Surface Electromyography (EMG) and Electrodermal response
Type of treatment
Injection or infusion
Could I receive a placebo?
No, everyone receives an active treatment
How many people
1,540 participants
Where
1 siteFrance
Study dates
11 Jul 2011to 11 Jul 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 5 to 71 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • Male or female aged 5 to 71
  • Subject affiliated to the general social security scheme or a similar scheme
  • Subject agreeing to participate in the study with informed consent -Capable of understanding information and simple instructions related to the study

Who cannot join

  • Subject under tutelage or guardianship- Subject under tutelage or guardianship
  • Subject not able to give informed consent, unable to receive information about the study
  • Subject not affiliated to a French or non-French social security system holder of a European health insurance card

Trial locations and contacts

1 site in 1 country.

France1 site, 1 recruiting
  • Hospices Civils de Lyon

    Saint-Genis-Laval, 69230

    Gilles RODE, MD, 04 78 86 50 66 ext. +33, gilles.rode@chu-lyon.fr

    Recruiting

Other trials in France

About this study

Official title: Cerebral Bases of Multisensory Perception of the Body and Its Action Space

To accurately control body movements to interact with objects, our brain needs representations of the body and the nearby space. The broader aim of this research project is to study the behavioural and physiological mechanisms involved in the constitution of these representations, to identify their neural bases, in order to better understand the dysfunctions in the context of neurological or developmental disorders.

Conditions
Healthy, Blindness
Being tested
Electrooculogram (EOG), Surface Electromyography (EMG), Electrodermal response, Changes in skin temperature, MRI
Keywords
Stroke, Multisensory, Plasticity, Body, Space, MRI
Medical subject headings
Blindness, Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Electrooculogram (EOG)Other

    Also called Eye-tracker

    The acquisition of the surface EOG activity will be carried out by means of 3 surface electrodes, one of which, referred to as a reference, is placed on a bone zone (the glabella, above the nasion) and two others placed on The temples, coupled to an EOG amplifier.

  • Surface Electromyography (EMG)Other

    In behavioral or transcranial stimulation protocols, surface EMG activity may be recorded for further analysis. No protocol included in this project will involve the recording of intramuscular electromyographic activity, which is invasive and involves the implantation of needle electrodes into the muscles.

  • Electrodermal responseOther

    The electrodermal response is a useful, simple and reproducible method for recording sweat gland activity that reflects autonomic nervous activity. Recordings will be made using traditional devices, including an amplifier (Delsys or BrainAMP or equivalent) as well as disposable electrodes.

  • Changes in skin temperatureOther

    The skin temperature will therefore be recorded during behavioral protocols using techniques for manipulating the representation of the body (perceptual illusion, prismatic deviation, etc.) using a specific measuring device.

  • MRIOther

    Whatever the protocol, a diffusion tensor MRI (DTI) acquisition sequence as well as an image of the entire brain and high spatial resolution (T1 weight, 1x1x1 mm, nasion markers and pre-atrial points) will be acquired (Total duration: 20 minutes).

  • MEGOther

    During the examination, the subject will have to perform tasks comparable to those described for the fMRI procedure, but with the additional possibility, offered by the MEG environment, of performing pointing or seizing of objects, provided that the Trunk and the subject's head be held in place by a suitable restraint system.

  • Transcranial magnetic stimulation (TMS)Other

    TMS is a non-invasive technique that uses very short (~ 100μs) magnetic pulses applied to the scalp to transiently and focally disrupt or improve the functioning of neuronal populations in the underlying superficial cortical regions.

  • Transcranial electrical stimulation in direct current (tDCS)Other

    The tDCS consists in passing a current of low intensity (generally ≤ 1mA to stimulate the cerebral cortex) between an anode and a cathode placed on the scalp, a part of this current crossing the tissues, and in particular the cortical regions situated between these two Electrodes. Generally, if the cathode is placed on the region of interest, it will be inhibited, while it will be energized if the anode is positioned thereon.

Study groups in NCT03201341
Study groupRoleWhat they receive
Behavioral protocolOtherTo better understand the normal functioning of the brain within the framework of the representation of the body and of the space of action. During the experiment, physiological measurements will be recorded: electrical activity at the surface of the muscles (electromyography - EMG), scalp (electroencephalography - EEG) or skin (electrodermal response). Similarly, the movements of the arm will be recorded using an infrared kinematic system requiring simply the placement of markers at strategic points such as the tip of the thumb and forefinger, the wrist, the elbow ... Movements of the eyes can also be recorded, either with the aid of an electrooculograph (EOG) or with the aid of an infrared tracking device. Electrotactile stimulations of very low intensity and painless can also be administered.
Receives: Other: Electrooculogram (EOG); Other: Surface Electromyography (EMG); Other: Electrodermal response; Other: Changes in skin temperature
Study in fMRIOtherTo better understand the normal functioning of the brain in the representation of the body and the space of action, to identify the brain areas critical for these functions and to determine their functional roles. The examination will consist of several very short scans at the very beginning and then a scan of about ten minutes intended to take a detailed anatomical image of the brain. Then, the subject will carry out the experimental task during one or more scan (s) whose cumulative duration will not exceed 45 minutes. The task accomplished is explained in detail by the experimenter.
Receives: Other: MRI
Study in MEGOtherTo better understand the normal functioning of the brain in the representation of the body and the space of action, to identify the critical brain areas for these functions and to determine their functional roles and to study how They interact.The complete examination includes a magnetoencephalography (MEG) experiment followed by an MRI examination. The task accomplished is explained in detail by the experimenter.
Receives: Other: MRI; Other: MEG
Study in TMSOtherTo better understand the normal functioning of the brain in the representation of the body and the space of action, to determine the functional role of the brain areas involved in these processes. Before the Transcranial magnetic stimulation (TMS) examination, MRI of the brain will be performed.The TMS review will consist of three distinct sessions separated from one another by at least one week, depending on the protocol, and which will differ simply at the site or type of stimulation.
Receives: Other: MRI; Other: Transcranial magnetic stimulation (TMS)
Study in tDCSOtherTo better understand the normal functioning of the brain in the representation of the body and the space of action, to determine the functional role of the cerebral areas involved in these processes. The transcranial Direct Current Stimulation (tDCS) exam will consist of three separate sessions separated from each other by at least one week and will simply differ at the stimulation site. The task accomplished is explained in detail by the experimenter.
Receives: Other: Transcranial electrical stimulation in direct current (tDCS)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Behavioural measure: reaction times

    Mesure of reaction times.

    Measured: Day 30

  2. Behavioural measure : accuracy

    Mesure of accuracy. Measurement of the accuracy of the realization of the implicit and explicit tasks according to the different approaches.

    Measured: Day 30

  3. Number of particpants with changed kinematics , via 3D optoelectronic motion tracking systems

    Both latency and amplitude measures will be analysed for the presence of altered mouvement patterns in velocity, accelleration, deceleration of the arm and grip formation for the hand.

    Measured: Day 30

Secondary outcomes (2)
  1. Physiological Indices

    Mesure with imaging

    Measured: Day 30

  2. Neuronal response indices

    Bold, Evoked Fields, Evoked Potentials

    Measured: Day 120

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Jun 2017
  2. Study start11 Jul 2011
  3. Primary completion11 Jun 2022 (estimated)
  4. Study completion11 Jul 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
1,540 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03201341
Sponsor's protocol ID
69HCL16_0650
Status last verified
Jul 2021
First submitted
29 Mar 2017
Last updated
20 Jul 2021
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Electrooculogram (EOG), Surface Electromyography (EMG) and Electrodermal response in people with Healthy and Blindness, run by Hospices Civils de Lyon at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 20 Jul 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Gilles RODE, MD (04 78 86 50 66 ext. +33, gilles.rode@chu-lyon.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Behavioural measure: reaction times (time frame: Day 30). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Jul 2021.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in